Sep 23, 2024, 14:15
Silvia Marchesi: Erythrocytosis in thyroid cancer patients undergoing oral treatment
Silvia Marchesi, Oncology resident at National Institute of Cancer, shared on X:
” Excited to have shared during ESMO 2024 the results of our study on erythrocytosis in thyroid cancer patients undergoing oral treatment.
A huge thank you to my mentors for their support throughout this project Prof Lisa Licitra, Salvatore Alfieri and Prof Laura Locati.”
Source: Silvia Marchesi/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 25, 2025, 15:10
Feb 25, 2025, 14:12
Feb 25, 2025, 14:04
Feb 25, 2025, 13:56
Feb 25, 2025, 13:46
Feb 25, 2025, 13:38
Feb 25, 2025, 11:33